Clinical Trial Update: A First-In-Human Study of RO5503781 in Participants With Advanced Malignancies Except Leukemia [Phase 1]

View source ↗

Summary

This is a first-in-human Phase 1 study of RO5503781 in participants with advanced cancers excluding leukemia. The trial, sponsored by Hoffmann-La Roche, has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• RO5503781

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Neoplasms | Phase 1 | Status: COMPLETED